DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue S 2 · Volume 32 · June 2006 DOI: 10.1055/s-002-4996 Current and Future Hemophilia Treatment Options Based on the 15th Annual Hemophilia Research Study Update Leonard A Valentino M.D. Edward Gomperts M.B.B.Ch. M.D. Bruce Ewenstein M.D. Ph.D.

PREFACE

  • 001
    Valentino, Leonard A.:

    Current and Future Hemophilia Treatment Options Based on the 15th Annual Hemophilia Research Study Update

  • 003
    Knight, Richard; Stanley, Samuel; Wong, Michael; Dolan, Gerard:

    Hemophilia Therapy and Blood-Borne Pathogen Risk

  • 010
    Lee, Christine A.; Lillicrap, David; Astermark, Jan:

    Inhibitor Development in Hemophiliacs: The Roles of Genetic versus Environmental Factors

  • 015
    Hay, Charles; Recht, Michael; Carcao, Manuel; Reipert, Birgit:

    Current and Future Approaches to Inhibitor Management and Aversion

  • 022
    Berntorp, Erik; Gringeri, Alessandro; Leissinger, Cindy; Négrier, Claude; Key, Nigel:

    New Approaches to Using FEIBA in the Treatment of Inhibitor Patients

  • 028
    Valentino, Leonard A.; Santagostino, Elena; Blanchette, Victor; van den Berg, Marijke:

    Managing the Pediatric Patient and the Adolescent/Adult Transition

  • 032
    Valentino, Leonard A.; Scheiflinger, Friedrich:

    Future Aspects of Hemophilia Research and Care

  • 039
    Berntorp, Erik; Gomperts, Edward; Hoots, Keith; Wong, Wing-Yen:

    The Next Generation of Hemophilia Treatment Specialists